ALK and anaplastic large cell lymphoma: This was followed by a randomized, phase III clinical study directly comparing ASCT and alloSCT in 104 transplant-eligible patients with PTCL (except ALK-positive ALCL) following CR with four cycles of CHOEP induction chemotherapy.